Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

Returns vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

ANG Lifesciences India hit an upper circuit limit of 5% at Rs 521.65 after the company said it will invest in the equity shares of ANG Healthcare India.

ANG Lifesciences spurts after acquisition

Board of ANG Lifesciences approves acquisition of ANG Healthcare India

The acquisition will help company in its brand-building, domestic branding and direct marketing initiative for the purposes of staying close to the customer.

ANG Lifesciences soars 5% after board announces plan to invest in ANG Healthcare India

Ambition Mica Ltd, Supreme Infrastructure India Ltd, Aditya Vision Ltd and ANG Lifesciences India Ltd are among the other losers in the BSE’s ‘B’ group today, 23 November 2021.

Starlineps Enterprises Ltd leads losers in ‘B’ group

R S Software (India) Ltd, Vikas Wsp Ltd, Patel Integrated Logistics Ltd and ANG Lifesciences India Ltd are among the other losers in the BSE’s ‘B’ group today, 09 November 2021.

Gujarat Lease Financing Ltd leads losers in ‘B’ group

Board of ANG Lifesciences India approves acquisition majority stake in Baddi Agro

The fully paid-up Bonus Shares shall be distributed to the Members of the Company, whose names appear in the Register of Members.

ANG Lifesciences India fixes Sept 23 as record date for bonus issue; Stock jumps 3%

This acquisition is in line with ANG’s long-term strategic objective to become a complete Healthcare Solution Provider.

ANG Lifesciences acquires two formulation manufacturing facilities of Ind-Swift; stock hits record high

The company is engaged primarily in the business of manufacturing and marketing of finished pharmaceutical formulations.

Infomerics assigns ‘BBB-/Stable’ rating on ANG Lifesciences bank facilities

Stocks to watch out for today are Adani Enterprises, ITNL, PNC Infratech, Olectra Greentech, Ashiana Housing and ANG Lifesciences.

Lacklustre opening likely for markets ahead of RBI meet, results

BRIEF-ANG Lifesciences India Says Acquired Mansa Print & Publishers Ltd

ANG Lifesciences India is a pharmaceutical company, engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials

ANG Lifesciences India Ltd

ANG Lifesciences India Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

ANG Lifesciences spurts after acquisition

Board of ANG Lifesciences approves acquisition of ANG Healthcare India

ANG Lifesciences soars 5% after board announces plan to invest in ANG Healthcare India

Starlineps Enterprises Ltd leads losers in ‘B’ group

Gujarat Lease Financing Ltd leads losers in ‘B’ group

Board of ANG Lifesciences India approves acquisition majority stake in Baddi Agro

ANG Lifesciences India fixes Sept 23 as record date for bonus issue; Stock jumps 3%

ANG Lifesciences India Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

ANG Lifesciences spurts after acquisition

Board of ANG Lifesciences approves acquisition of ANG Healthcare India

ANG Lifesciences soars 5% after board announces plan to invest in ANG Healthcare India

Starlineps Enterprises Ltd leads losers in ‘B’ group

Gujarat Lease Financing Ltd leads losers in ‘B’ group

Board of ANG Lifesciences India approves acquisition majority stake in Baddi Agro

ANG Lifesciences India fixes Sept 23 as record date for bonus issue; Stock jumps 3%

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

Returns vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's return on equity is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock